4.2.3.1. Case Ascertainment: the identification of reportable cases for UTMB in the inpatient and outpatient settings. 4.2.3.2. Suspense File: Ongoing maintenance and review of the cancer database suspense file 4.2.3.3. Abstracting: Abstract reportable cases in accordance with the CoC and SCR guidelines 4.2.3.4. Data collection: the abstraction, coding and staging of identified cases via medical record review and input into a cancer registry software. 4.2.3.5. Patient Follow-up: the monitoring on an annual basis of analytical cases and data input for outcome-based data. 4.2.3.6. Data Reporting: weekly/monthly transmission of collected data to regulatory agencies, annual report production, ad-hoc reports, patient care evaluations and special request handling in alignment with the Texas Reporting Calendar. UTMB will require Supplier to meet State expectations to prevent UTMB from placement on Reporting Improvement Plan (RIP). UTMB will not accept any Supplier that places UTMB on RIP for consecutive quarters with the State. 4.2.3.7. Quality Assurance Monitors: assure accurate and complete data collection, meeting regulatory agency requirements. 4.2.3.8. Physician Quality Review: Maintain the documentation and make corrections resulting from physician 10% review of the annual analytical caseload as needed 4.2.3.9. Quality Improvement Studies: Assist UTMB's Quality Improvement Coordinator with the completion and follow-up of Quality Improvement studies as required, with the required involvement of the cancer committee and designated physician representatives 4.2.3.10. Data Security: confidentiality of all information contained within and about the registry database as well as UTMB privileged information.
